Programme

I. Surface ECG

1. Algorithm for diagnosis the culprit coronary artery and the location of occlusion in STEMI
Drs. A Bayés de Luna – M. Fiol

2. Different ECG patterns at presentation in ACS.
Drs. D Goldwasser - A Bayés de Luna –  M Santaló - K. Nikus

3. Differential diagnosis of ST segment elevation patterns
Dr. Y Birnbaum

4. The ECG in Acute Coronary Syndromes (Parts I and II)
Dr. Hein Wellens

5. New terminology of the walls of the heart and new classification of Q-wave MI based on the standards of CMR
Drs. A Bayés de Luna, G Wagner, W Zareba

6. ECG Changes that occur during coronary spasm
Dr. A. Bayes de Luna, S. Stern

7. Identification of ACS or chronic MI in patients with LBBB
Drs. A Bayés-Genis, A. Pérez Riera,  A Bayés de Luna

8. Significance of ST segment resolution patterns following fibrinolysis in STEMI
Dr. Ben Scirica

9. Detection of the infarct-related coronary artery by ECG analysis
Dr. Xiaomei Guo

10. The importance of proper ECG analysis for decision-making in the catheterization laboratory
Dr. Kjell Nikus, Markku Eskola

II. Holter Monitoring

1. Risk stratification based on ischemia detected on continuous ECG monitoring in Non-ST-elevation acute coronary syndromes
Dr. Ben Scirica

2. Significance of pharmacologic intervention in non-ST-elevation acute coronary syndromes as assessed by continuous ECG monitoring
Dr. Ben Scirica

3. Morphologic variability: A new electrocardiographic technique for risk stratification after non-ST-elevation acute coronary syndromes
Dr. Zeeshan Syed

4. Patterns of STEMI as assessed by Holter monitoring: significance of patterns of ST segment resolution
Dr. Peter Stone

5. Significance of ST-segment resolution patterns following fibrinolysis for ST-elevation MI
Dr. Ben Scirica

6. ST segment monitoring in patients with acute coronary syndrome
Dr. Anatoly Langer

7. The effect of ranolazine on the incidence of arrhythmias in patients with non-ST-segment elevation after acute coronary syndromes. Results from the MERLIN-TIMI 36 Trial
Dr. Ben Scirica

8.   Heart rate turbulence and deceleration capacity
Dr. Georg Schmidt

III. T wave Alternans

1. T-wave alternans detection during routine exercise testing and Holter monitoring
Dr. Richard Verrier

2. Comparison of T wave alternans profiles of healthy subjects and patients with ICDs-Part I
Dr. Euler de Vilhena Garcia, Nelson Samesima, Carlos Alberto Pastore

3. Comparison of T wave alternans profiles of healthy subjects and patients with ICDs-Part II
Dr. Euler de Vilhena Garcia, Nelson Samesima, Carlos Alberto Pastore

4. Exercise-based T-wave alternans testing for risk assessment and clinical decision-making
Dr. Thomas Kleigenhaben

5. AECG-based T-wave Alternans analysis for sudden death risk stratification
Dr. Maria Teresa La Rovere

IV. Exercise Testing

1. Exercise testing in Women
Dr. Anthony Morise

2. ACS Risk Stratification – The Exercise Test
Dr. Bernard Chaitman

3.  Electrocardiographic score to evaluate myocardial ischemia through the Exercise Test
Dr. Augusto Uchida

4. Simple heart rate adjustment of ST segment depression during exercise testing
Dr. Paul Kligfield

V. Pharmacological Management of IHD

A.  Stable CAD

1.  Understanding chronic coronary artery disease: obstructive stable lesions versus non-obstructive vulnerable plaque
Dr. Peter Stone

2.  Coronary artery disease treatment
Dr. Dennis Cokkinos

3.  Women and coronary artery disease
Dr. Giuseppe Rosano

4.  Ranolazine: New treatment paradigm for myocardial ischemia and myocardial dysfunction
Dr. Peter Stone

5.  The effect of ranolazine on the incidence of arrhythmias in patients with non-ST-segment elevation acute coronary syndrome: Results from the MERLIN-TIMI 36 Trial
Dr. Ben Scirica

6.  Trimetazidine in patients with ischemic cardiomyopathy
Dr. Juan Carlos Kaski, Vicente Bertomeu-Gonzalez

7. Metabolic modulation in patients with angina and type 2 diabetes
Dr. Giuseppe Rosano

8.  Nicorandil in angina
Dr. Debashis Roy

9.  Heart rate control in the treatment of angina - ivabradine
Prof Dr. John Camm

10.  Practical aspects of the use of ivabradine
Prof Dr. John Camm, A Timmis

11. Review of on-pump versus off-pump coronary artery bypass graft surgery
Dr. Reza Motallebzadeh, Marjan Jahangiri

12. On-pump and off-pump coronary artery bypass graft surgery
Dr. Reza Motallebzadeh, Marjan Jahangiri

13. Variant angina pectoris
Dr. Juan Carlos Kaski, Ramon Arroyo-Espliguero

14. Management of coronary artery spasm
Dr. Juan Carlos Kaski, Ramon Arroyo-Espliguero

15. Chest pain with normal coronary arteries
Dr. Juan Carlos Kaski

16. Treatment of patients with cardiac syndrome X
Dr. Gaetano Lanza

17. Management of patients with angina and type 2 diabetes
Dr. Dimitrios Tziakas

18. Markers of post myocardial infarction remodeling
Dr. Dimitrios Tziakas

B. Acute Coronary Syndromes (ACS)

1. Management of patients with non-ST-elevation MI and unstable angina: An overview
Dr. Jennifer Adgey, Colum Owens

2. ESC Guidelines for the management of non-ST segment elevation acute coronary syndromes
Dr. Jean-Pierre Bassand, Diego Ardissino, Andrzej Budaj, Eric Boersma, Francisco Fernandex-Aviles, Christian Hamm, Keith Fox, David Hasdai, Magnus Ohman, Lars Wallentin, William Wijns

3. Oral antiplatelet therapy in percutaneous coronary intervention/acute coronary syndrome
Dr. Dominick Angiolillo

4. Variability in responsiveness to antiplatelet therapy
Dr. Dominick Angiolillo

5. Novel antiplatelet agents
Dr. Dominick Angiolillo

6. Optimizing anti-thrombotic therapy
Dr. Magda Heras

7.  Ranolazine in the management of patients with non-ST segment elevation acute coronary syndromes: The MERLIN TIMI 36 Trial
Dr. David Morrow

8. Reflections on pathology and management of acute myocardial infarction
Dr. Nykola Yabluchansky

9. In-vivo identification of high-risk coronary plaque from endothelial shear stress and expansive vascular remodeling
Dr. Peter Stone

C. Secondary prevention

1.  Secondary prevention after myocardial infarction in the UK – Implementing NICE guidance
Dr. Juan Carlos Kaski

2.  Secondary prevention of cardiovascular disease: The role of ACE inhibitors and angiotensin receptor blockers
Dr. Daniel Fernandez Berges

3.  Triflusal in the secondary prevention of coronary artery disease and other indications in cardiovascular disease
Dr. Juan Carlos Kaski, Jose Cruz-Fernandez, Matias Jordi

4.  Triflusal in cardiac disease
Dr. Jose Luis Lopez Sendon, Juan Carlos Kaski

5. The role of statins – New approaches
Dr. Kausik Ray